|
|
Article: Genetically modified bone marrow cells produce tolerance to self antigens.
- Article from:
- Drug Week
- Article date:
- October 1, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 OCT 1 - (NewsRx.com & NewsRx.net) -- Genetically modified bone marrow cells produce tolerance to self antigens.
"The challenge of finding a lasting cure for autoimmune disease(s) has not been met. Although the use of systemic anti-inflammatory agents still dominates the treatment of these diseases, there is a push towards developing novel and more specific strategies. In addressing autoimmunity, there is the intrinsic need to understand the mechanisms that lead to the development and maintenance of immunological tolerance to self-antigens," scientists in Australia argue.
"Experimental evidence has shown that directed antigen expression in the ...